SARS-CoV-2 Antigen Rapid Test for COVID-19 Coronavirus 2, diagnosis of COVID-19 pandemic within 15mins.
Intended Use:
SARS-CoV-2 Antigen Rapid Test (Lateral Flow Immunoassay, LFI) is intended for the
in vitro qualitative detection of the SARS-CoV-2 nucleocapsid (N) antigen from human
nasopharyngeal or oropharyngeal swabs, sputa and saliva specimens.
Testing Principle:
SARS-CoV-2 Antigen Rapid Test is based on the lateral flow immunoassay. The kit
has a colloid gold conjugated mouse anti-SARS-CoV-2 N protein monoclonal antibody contained
in the sample pad. It also has a SARS-CoV-2 N protein monoclonal antibody pre-coated on the
detection line (T) of the membrane strip. If the tested specimen contains the SARS-CoV-2 N
antigen, the two monoclonal antibodies and the N antigen form a gold antibody–antigen–antibody
complex, and a visible purple band may appear at the detection line (T). Also, another visible
purple band may appear at the control line (C), indicating the accurate performance of the test.
How to use it ?
Contact me for more information
